Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction [NA]
The Johns Hopkins University-sponsored clinical trial investigating IL-10 levels and remote ischemic preconditioning in acute myocardial inf…
-
FDA approval · 2016-03-21FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lopressor (metoprolol tartrate) filed by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2016-03-21Clinical Trial Update: Wiser Choices in Acute Myocardial Infarction [NA]
The Mayo Clinic-sponsored clinical trial in Acute Myocardial Infarction has completed. The provided snippet does not include trial results.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Thrombolysis in Myocardial Ischemia Trial (TIMI III) [Phase 3]
The Phase 3 TIMI III trial evaluating thrombolysis in myocardial ischemia has completed, with an update posted on the trial registry.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Thrombolysis in Myocardial Infarction (TIMI) [Phase 3]
The TIMI Phase 3 trial update indicates the study has completed; no results are reported in this document.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Predictors of Perioperative Cardiac Morbidity
The clinical trial results update on predictors of perioperative cardiac morbidity has completed, identifying factors associated with cardia…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction
Update on the MAP-IDM trial investigating molecular markers of sudden death during the acute phase of myocardial infarction; the study statu…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Inflammation, Infection, and Future Cardiovascular Risk
This is a completed NHLBI clinical trial update examining how inflammation and infection relate to future cardiovascular risk. It discusses …
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Triggers of Ventricular Arrhythmias (TOVA) Study
Clinical trial update on the Triggers of Ventricular Arrhythmias (TOVA) study; the study examining triggers of ventricular arrhythmias in ca…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Thrombotic, Inflammatory & Gene Markers of CVD in Women
A completed NHLBI-sponsored clinical trial studied thrombotic, inflammatory, and genetic markers of cardiovascular disease in women, includi…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Physicians' Health Study: Study of Low Cardiovascular Disease Mortality
Clinical trial update for the Physicians' Health Study examining low cardiovascular disease mortality. The study is sponsored by the Nationa…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Compliance in the Physicians' Health Study
This report documents the completion of a study evaluating participant compliance in the Physicians' Health Study, a NHLBI-sponsored trial i…
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock [Phase 2]
A Phase 2 clinical trial evaluating cyclosporine in acute myocardial infarction complicated by cardiogenic shock has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Flavonoids and Cardiovascular Disease
A clinical trial evaluating flavonoids for cardiovascular disease has completed.
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Observational Aspirin Use and CVD in the Physicians' Health Study
This update reports observational findings from the Physicians' Health Study on aspirin use and cardiovascular disease outcomes.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Evans County Studies
NHLBI-sponsored clinical trial in Evans County has completed; the study investigated cardiovascular conditions including myocardial infarcti…
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients
This document provides an update on a clinical trial investigating immunologic features in peripheral blood and aspirated thrombi in acute m…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
The clinical trial update summarizes the incidence of diabetes and cardiovascular disease in Mexican Americans and notes the study status as…
-
FDA approval · 2016-03-02FDA Approved: KENGREAL — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for KENGREAL (cangrelor) from Chiesi USA, Inc., resulting in an updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Predictors of Cardiovascular Disease in the Elderly
The NHLBI-sponsored trial evaluating predictors of cardiovascular disease in older adults has completed, with findings expected to identify …
-
FDA approval · 2016-02-25FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for enalapril maleate from Taro Pharmaceuticals U.S.A., Inc., confirming approval of a generic e…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Program on Surgical Control of Hyperlipidemias (POSCH) [Phase 3]
Phase 3 POSCH trial on surgical control of hyperlipidemias has completed; no results are provided in this update.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Minnesota Heart Health Program
The Minnesota Heart Health Program clinical trial conducted by the University of Minnesota has completed.
-
FDA approval · 2016-02-24FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Half-Dose Radiopharmaceutical in Wide Beam Reconstruction [NA]
A trial evaluating a half-dose radiopharmaceutical for imaging in patients with myocardial infarction and ischemic heart disease was termina…